Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1961 1
1965 2
1968 1
1977 2
1978 1
1979 1
1980 4
1981 3
1982 2
1983 3
1984 4
1985 3
1986 5
1987 7
1988 3
1989 7
1990 8
1991 6
1992 9
1993 3
1994 7
1995 6
1996 10
1997 11
1998 14
1999 16
2000 16
2001 19
2002 14
2003 18
2004 10
2005 10
2006 17
2007 8
2008 17
2009 17
2010 11
2011 23
2012 23
2013 24
2014 21
2015 25
2016 22
2017 21
2018 30
2019 19
2020 32
2021 30
2022 44
2023 35
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

596 results

Results by year

Filters applied: . Clear all
Page 1
Oral rivaroxaban for symptomatic venous thromboembolism.
EINSTEIN Investigators; Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, Schellong S. EINSTEIN Investigators, et al. Among authors: cohen a. N Engl J Med. 2010 Dec 23;363(26):2499-510. doi: 10.1056/NEJMoa1007903. Epub 2010 Dec 3. N Engl J Med. 2010. PMID: 21128814 Free article. Clinical Trial.
CONCLUSIONS: Rivaroxaban offers a simple, single-drug approach to the short-term and continued treatment of venous thrombosis that may improve the benefit-to-risk profile of anticoagulation. ...
CONCLUSIONS: Rivaroxaban offers a simple, single-drug approach to the short-term and continued treatment of venous thrombosis that ma …
Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
Cohen AT, Hamilton M, Mitchell SA, Phatak H, Liu X, Bird A, Tushabe D, Batson S. Cohen AT, et al. PLoS One. 2015 Dec 30;10(12):e0144856. doi: 10.1371/journal.pone.0144856. eCollection 2015. PLoS One. 2015. PMID: 26716830 Free PMC article. Review.
A systematic review and network meta-analysis (NMA) were conducted to compare the efficacy and safety of NOACs for the initial and long-term treatment of VTE. METHODS: Electronic databases (accessed July 2014) were systematically searched to identify RCTs evaluating apixab …
A systematic review and network meta-analysis (NMA) were conducted to compare the efficacy and safety of NOACs for the initial and long-t …
Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study.
Dimopoulos MA, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, Garcia-Sanz R, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyz J, Fernández de Larrea C, Belada D, Libby E, Matous J, Motta M, Siddiqi T, Tani M, Trněný M, Minnema MC, Buske C, Leblond V, Treon SP, Trotman J, Chan WY, Schneider J, Allewelt H, Patel S, Cohen A, Tam CS. Dimopoulos MA, et al. Among authors: cohen a. J Clin Oncol. 2023 Nov 20;41(33):5099-5106. doi: 10.1200/JCO.22.02830. Epub 2023 Jul 21. J Clin Oncol. 2023. PMID: 37478390 Clinical Trial.
The phase III ASPEN study demonstrated the comparable efficacy and improved safety of zanubrutinib versus ibrutinib in patients with Waldenstrom macroglobulinemia (WM). Here, we report long-term follow-up outcomes from ASPEN. The primary end point was the sum of very good …
The phase III ASPEN study demonstrated the comparable efficacy and improved safety of zanubrutinib versus ibrutinib in patients with Waldens …
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
EINSTEIN–PE Investigators; Büller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, Minar E, Chlumsky J, Verhamme P, Wells P, Agnelli G, Cohen A, Berkowitz SD, Bounameaux H, Davidson BL, Misselwitz F, Gallus AS, Raskob GE, Schellong S, Segers A. EINSTEIN–PE Investigators, et al. Among authors: cohen a. N Engl J Med. 2012 Apr 5;366(14):1287-97. doi: 10.1056/NEJMoa1113572. Epub 2012 Mar 26. N Engl J Med. 2012. PMID: 22449293 Free article. Clinical Trial.
CONCLUSIONS: A fixed-dose regimen of rivaroxaban alone was noninferior to standard therapy for the initial and long-term treatment of pulmonary embolism and had a potentially improved benefit-risk profile. ...
CONCLUSIONS: A fixed-dose regimen of rivaroxaban alone was noninferior to standard therapy for the initial and long-term treatment of …
Post-Natal Short-Term Home Visiting Programs: An Overview and a Volunteers-Based Program Pilot.
Gross Manos D, Bader NG, Cohen A. Gross Manos D, et al. Among authors: cohen a. Int J Environ Res Public Health. 2023 Aug 25;20(17):6650. doi: 10.3390/ijerph20176650. Int J Environ Res Public Health. 2023. PMID: 37681790 Free PMC article. Review.
To address this problem, this paper reviews the literature on home visits conducted shortly after giving birth, considering different types of programs and their outcomes, while focusing on short-term and volunteer-based programs, two approaches that can answer the …
To address this problem, this paper reviews the literature on home visits conducted shortly after giving birth, considering different …
Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal DREAMM-2 study.
Lonial S, Lee HC, Badros A, Trudel S, Nooka AK, Chari A, Abdallah AO, Callander N, Sborov D, Suvannasankha A, Weisel K, Voorhees PM, Womersley L, Baron J, Piontek T, Lewis E, Opalinska J, Gupta I, Cohen AD. Lonial S, et al. Among authors: cohen ad. Cancer. 2021 Nov 15;127(22):4198-4212. doi: 10.1002/cncr.33809. Epub 2021 Jul 27. Cancer. 2021. PMID: 34314018 Free PMC article. Clinical Trial.
BACKGROUND: On the basis of the DREAMM-2 study (ClinicalTrials.gov identifier NCT03525678), single-agent belantamab mafodotin (belamaf) was approved for patients with relapsed or refractory multiple myeloma (RRMM) who received 4 prior therapies, including anti-CD38 therapy. The a …
BACKGROUND: On the basis of the DREAMM-2 study (ClinicalTrials.gov identifier NCT03525678), single-agent belantamab mafodotin (belamaf) was …
Dyslipidemia.
Cohen AM, Rader DJ. Cohen AM, et al. Curr Treat Options Cardiovasc Med. 2001 Aug;3(4):347-357. doi: 10.1007/s11936-001-0096-4. Curr Treat Options Cardiovasc Med. 2001. PMID: 11445064
The major goal in treatment of patients with dyslipidemia is to decrease the short- and long-term incidence of cardiovascular events, including myocardial infarction, unstable angina, stroke, and death. ...
The major goal in treatment of patients with dyslipidemia is to decrease the short- and long-term incidence of cardiovascular events, …
Cardiovascular manifestations secondary to COVID-19: A narrative review.
Fauvel C, Trimaille A, Weizman O, Pezel T, Mika D, Waldmann V, Cohen A, Bonnet G. Fauvel C, et al. Among authors: cohen a. Respir Med Res. 2022 May;81:100904. doi: 10.1016/j.resmer.2022.100904. Epub 2022 May 4. Respir Med Res. 2022. PMID: 35525097 Free PMC article. Review.
Finally, worsening of previous cardiovascular disease as a result of COVID-19 will be examined, as well as long-term COVID-19 effects and cardiovascular complications of COVID-19 vaccines....
Finally, worsening of previous cardiovascular disease as a result of COVID-19 will be examined, as well as long-term COVID-19 effects …
A Dynamic Method, Analysis, and Model of Short-Term Memory for Serial Order with Clinical Applications.
Cheng S, Cohen AS, Holmlund TB, Foltz PW, Cheng J, Bernstein JC, Rosenfeld EP, Elvevåg B. Cheng S, et al. Among authors: cohen as. Psychiatry Res. 2020 Dec;294:113494. doi: 10.1016/j.psychres.2020.113494. Epub 2020 Oct 6. Psychiatry Res. 2020. PMID: 33217720 Free article.
In terms of temporal dynamics, this is the first demonstration of primacy and recency effects in time domain variables, as well as phonological similarity effects as evident by the inverted U-shaped curves in time. The speed of short-term memory processes affects accuracy, …
In terms of temporal dynamics, this is the first demonstration of primacy and recency effects in time domain variables, as well as phonologi …
The long-term prognostic significance of sarcoidosis-associated pulmonary hypertension - A cohort study.
Tiosano S, Versini M, Dar Antaki L, Spitzer L, Yavne Y, Watad A, Gendelman O, Comaneshter D, Cohen AD, Amital H. Tiosano S, et al. Among authors: cohen ad. Clin Immunol. 2019 Feb;199:57-61. doi: 10.1016/j.clim.2018.12.012. Epub 2018 Dec 10. Clin Immunol. 2019. PMID: 30543925
In small scale studies, it has been previously described as manifestation of advanced disease and was found to be associated increased morbidity and mortality. This study sought to assess the long-term prognostic significance of sarcoidosis-associated pulmonary hypertensio …
In small scale studies, it has been previously described as manifestation of advanced disease and was found to be associated increased morbi …
596 results